Myocardial infarction and deep venous thrombosis in a young patient with Behçet disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 1, 2006, Pages 105-109

  Çalgüneri, Meral ^a   Aydemir, Kudret ^a   Öztürk, Mehmet Akif ^a,b   Haznedaroǧlu, Ibrahim C ^a   Kiraz, Sedat ^a   Ertenli, Ihsan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Ostim Mahallesi   (Turkey)

Author keywords

Beh et's disease; Hypercoagulability; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; BENZATHINE PENICILLIN; COLCHICINE; ENALAPRIL; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; DISEASE COURSE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; LABORATORY TEST; MALE; MOUTH ULCER; PHYSICAL EXAMINATION; POPLITEAL VEIN; PRIORITY JOURNAL; RELAPSE; ST SEGMENT ELEVATION; SYSTEMIC VASCULITIS; UVEITIS;

ADULT; BEHCET SYNDROME; CORONARY THROMBOSIS; HEMOSTASIS; HUMANS; MALE; MYOCARDIAL INFARCTION; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 32344432386     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200118     Document Type: Article

References (32)

1. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med 1999;341:1284.
2. Behçet H. Über rezidiverende aphthöse durch ein virus verursachte Geschwüre am Mund, am Auge, und an den Genitalien. Dermatol Wochenzchr 1937;105:1152.
3. International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078.
4. Drobinski G, Wechsler B, Pavie A, et al. Emergency percutaneous coronary dilatation for acute myocardial infarction in Behcet's disease. Eur Heart J 1987;8:1133.
5. Lakhanpal S, Tani K, Lie JT, et al. Pathologic features of Behçet's syndrome: A review of Japanase autopsy registry data. Hum Pathol 1985;16:790.
6. Siepmann M, Kirch W. Coronary anomaly in Behçet's syndrome. Rheumatol Int 1997;17:39.
7. Hutchison SJ, Belch JJ. Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis. Br Heart J 1984;52:686.
8. Schiff S, Moffatt R, Mandel WJ, et al. Acute myocardial infarction and recurrent ventricular arrhythmias in Behcet's syndrome. Am Heart J 1982;103:438.
9. Bowles CA, Nelson AM, Hammill SC, et al. Cardiac involvement in Behçet's disease. Arthritis Rheum 1985;28:345.
10. Ioakimidis D, Georganas C, Panagoulis C, et al. A case of Adamantiadis-Behçet's syndrome presenting as myocardial infarction. Clin Exp Rheumatol 1993;11:183.
11. Putini RL, Natale E, Di Marcotullio G, et al. Acute coronary syndrome and late stent failure in a patient with Behcet's syndrome. Ital Heart J 2003;4:281.
12. Hattori S, Kawana S. Behcet's syndrome associated with acute myocardial infarction. J Nippon Med Sch 2003;70:49.
13. Tezcan H, Yavuz S, Fak AS, et al. Coronary stent implantation in Behcet's disease. Clin Exp Rheumatol 2002;20:704.
14. Gullu IH, Benekli M, Muderrisoglu H, et al. Silent myocardial ischemia in Behcet's disease. J Rheumatol 1996; 23:323.
15. Koc Y, Gullu I, Akpek G, et al. Vascular involvement in Behçet's disease. J Rheumatol 1992;19:402.
16. Koşar A, Haznedaroǧlu IC, Büyükaşik Y, et al. Activated protein C resistance in Behçet's disease. Rheumatol Int 1998;17:249.
17. Gül A, Aslantas AB, Tekinay T, et al. Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology 1999;38:1298.
18. Haznedaroǧlu IC, Ozcebe O, Çelik I, et al. Haemostatic markers of procoagulant inbalance in Behçet's disease. Eur J Haematol 1996;57:107.
19. Haznedaroǧlu IC, Özcebe O, Özdemir O, et al. Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med 1996;240:181.
20. Haznedaroǧlu IC, Çelikl, Büyükaşik Y, et al. Haemostasis, thrombosis, and endothelium in Behçet's disease. Acta Haematol 1998;99:296.
21. Ozturk MA, Ozbalkan Z, Onat AM, et al. Decreased protein Z concentrations complicating the hypercoagulable state of Behcet's disease. Clin Appl Thromb Hemost 2003; 9:259.
22. Ertenli I, Kiraz S, Celik IC, et al. Changes in the concentration and distribution of tissue factor pathway inhibitor in Behcet's disease and systemic lupus erythematosus: Effect on the prethrombotic state. Ann Rheum Dis 2001; 60:1149.
23. Ozoran K, Dugun H, Curler A, et al. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Scand J Rheumatol 1995;24:376.
24. Haznedaroǧlu IC, Özdemir O, Özcebe O, et al. Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 1996;75:974.
25. Özcebe O, Haznedaroǧlu IC, Özdemir O, et al. Soluble thrombomodulin and fibrinolysis in Behçet's disease. Med Principles Pract 1996;5:146.
26. Haznedaroǧlu, Karaaslan Y, Büyükaşik Y, et al. Selectin adhesion molecule in Behçet's disease. Ann Rheum Dis 2000;59:61.
27. Haznedaroǧlu IC, Dündar SV, Kirazli Ş. Eicosanoids in the prethrombotic state of Behçet's disease. Thromb Res 1995; 80:445.
28. Kiraz S, Ertenli I, Ozturk MA, et al. Pathological haemostasis and "prothrombotic state" in Behcet's disease. Thromb Res 2002;105:125.
29. O'Duffy JD. Vasculitis in Behçet's disease. Rheum Dis Clin North Am 1990;16:423.
30. Barnes CG, Yazici H. Behçet's syndrome. Rheumatology 1999;38:1171.
31. Zouboulis CC, Orfanos CE. Treatment of Adamantiades-Behçet Disease with systemic interferon alfa. Arch Dermatol 1998;134:1010.
32. Çalgüneri M, Öztürk MA, Ertenli I, et al. Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: An open study. Ann Rheum Dis 2003;62:492.